Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127622771 | 12762277 | 1 | I | 201501 | 20160912 | 20160920 | 20160920 | EXP | US-GLAXOSMITHKLINE-US2016133245 | GLAXOSMITHKLINE | 71.42 | YR | F | Y | 0.00000 | 20160920 | CN | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127622771 | 12762277 | 1 | PS | ADVAIR DISKUS | FLUTICASONE PROPIONATESALMETEROL XINAFOATE | 1 | Respiratory (inhalation) | UNK | 21077 | INHALATION POWDER | |||||||||
127622771 | 12762277 | 2 | SS | ADVAIR DISKUS | FLUTICASONE PROPIONATESALMETEROL XINAFOATE | 1 | 500/50 UG | 21077 | INHALATION POWDER | ||||||||||
127622771 | 12762277 | 3 | SS | VENTOLIN HFA | ALBUTEROL SULFATE | 1 | UNK | D | 0 | ||||||||||
127622771 | 12762277 | 4 | C | CARDIA | AJMALINE | 1 | 0 | ||||||||||||
127622771 | 12762277 | 5 | C | LASIX | FUROSEMIDE | 1 | 0 | ||||||||||||
127622771 | 12762277 | 6 | C | SPIRIVA | TIOTROPIUM BROMIDE MONOHYDRATE | 1 | 0 | ||||||||||||
127622771 | 12762277 | 7 | C | ASPIRIN (BABY) | ASPIRIN | 1 | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
127622771 | 12762277 | 1 | Chronic obstructive pulmonary disease |
127622771 | 12762277 | 2 | Emphysema |
127622771 | 12762277 | 3 | Chronic obstructive pulmonary disease |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
127622771 | 12762277 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
127622771 | 12762277 | Coronary artery occlusion | |
127622771 | 12762277 | Drug dose omission | |
127622771 | 12762277 | Drug ineffective | |
127622771 | 12762277 | Dysphonia | |
127622771 | 12762277 | Dyspnoea | |
127622771 | 12762277 | Heart rate increased | |
127622771 | 12762277 | Nasopharyngitis | |
127622771 | 12762277 | Oxygen saturation decreased | |
127622771 | 12762277 | Pericardial effusion | |
127622771 | 12762277 | Pleural effusion | |
127622771 | 12762277 | Pneumonia |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
127622771 | 12762277 | 1 | 2011 | 0 | ||
127622771 | 12762277 | 2 | 201609 | 0 | ||
127622771 | 12762277 | 3 | 2011 | 0 |